Follicular development unfolds across a series of clearly defined stages, beginning with a dormant primordial follicle and ending, for a fortunate few follicles, with ovulation or transformation into the corpus luteum. The labeled stages are generally identified as primordial, primary, secondary, antral (also called tertiary), and preovulatory (Graafian), followed by the post-ovulatory corpus luteum. Each stage is distinguished by visible structural changes in both the egg cell and the surrounding support cells, which is why textbook diagrams can label them so neatly. But the biology driving each transition is anything but simple, involving crosstalk between the egg and its neighbors, shifting hormone sensitivities, and a brutal selection process that eliminates the vast majority of follicles before they ever reach maturity.
The Primordial Follicle Pool
The journey starts before birth. By around the twentieth week of fetal life, the ovaries have assembled their lifetime supply of primordial follicles, each consisting of a small, arrested egg cell (oocyte) surrounded by a single thin layer of flat cells called pre-granulosa cells. This pool represents the total reproductive reserve. Most of these follicles will remain dormant for years or even decades, held in a quiescent state by molecular brakes. One of the key signals maintaining dormancy is a protein called PTEN, which works through a pathway that keeps the follicle’s internal growth signals suppressed.1Frontiers in Cell and Developmental Biology. The Factors and Pathways Regulating the Activation of Mammalian Primordial Follicles in vivo Another protein, FOXO3, sits in the nucleus of the oocyte during dormancy and acts as a gatekeeper; when it gets shuttled out of the nucleus, the follicle receives the green light to wake up.2PubMed Central. FOXO3 and PTEN expression in the ovary of girls with extra-gonadal cancer with or without chemotherapy treatment prior to cryopreservation
This dormancy is critical. If too many primordial follicles activate at once, the reserve depletes prematurely, leading to early loss of fertility. The ovary keeps a tight lid on the rate of activation, releasing small batches of primordial follicles into the growth pipeline over the course of reproductive life. Anti-Müllerian hormone (AMH), produced by the granulosa cells of small growing follicles, acts as one of these brakes by inhibiting the recruitment of additional primordial follicles into the growing pool.3Molecular and Cellular Endocrinology. Anti-Müllerian hormone and its role in ovarian function
Activation and the Primary Follicle
When a primordial follicle leaves its dormant state, the first visible change is in the surrounding pre-granulosa cells: they shift from a flat shape to a cuboidal one. Once the oocyte is encircled by a complete layer of cuboidal granulosa cells, the follicle is labeled a primary follicle.4Journal of Cell Science. Effect of cell shape and packing density on granulosa cell proliferation and formation of multiple layers during early follicle development in the ovary At this stage, a glycoprotein coat called the zona pellucida begins forming between the oocyte and its granulosa cells. Tiny cellular projections called transzonal processes extend from the granulosa cells through the zona pellucida to maintain direct contact with the egg, ferrying nutrients and signaling molecules back and forth.
The trigger that selects which primordial follicles wake up and which remain asleep is still not fully understood, but research points to a conversation between the somatic (support) cells and the oocyte. The surrounding pre-granulosa cells appear to initiate the process: signaling through a pathway involving mTORC1 drives the pre-granulosa cells to differentiate and produce a molecule called KIT ligand (KITL). KITL then binds to receptors on the oocyte surface, activating growth signals within the egg itself and prompting it to begin developing.5Current Biology. Somatic Cells Initiate Primordial Follicle Activation and Govern the Development of Dormant Oocytes in Mice Even something as basic as the energy metabolism of granulosa cells matters: enhanced sugar breakdown (glycolysis) in granulosa cells can boost mTOR activity and push primordial follicles to activate.6PubMed Central. Enhanced glycolysis in granulosa cells promotes the activation of primordial follicles through mTOR signaling
This early activation phase is entirely independent of the menstrual cycle hormones that most people associate with fertility. Primordial-to-primary follicle transition happens continuously, even in prepubescent girls and during pregnancy, driven by local signals rather than by FSH or LH from the pituitary gland.
The Secondary Follicle
Once the granulosa cells begin multiplying, they stack into multiple layers around the oocyte, marking the transition to a secondary follicle (sometimes called a preantral follicle). The oocyte itself enlarges considerably during this stage. A new cell layer also appears outside the granulosa cells: the theca, which develops its own blood supply. The theca layer matters because it will eventually produce the androgen precursors needed for estrogen synthesis.
Gap junctions, tiny channels that connect neighboring granulosa cells, become especially important here. These junctions allow ions, small nutrients, and signaling molecules to flow between cells and from the granulosa layer to the oocyte. The oocyte itself actively shapes this communication by secreting factors like GDF9 and BMP15, which influence granulosa cell behavior, affecting everything from how fast the cells divide to how they differentiate.7PubMed Central. Molecular Aspects and Clinical Relevance of GDF9 and BMP15 in Ovarian Function BMP15, for instance, can reduce the expression of connexin 43, a key building block of gap junctions, which appears to fine-tune the degree of communication between granulosa cells at particular developmental moments.8PubMed Central. Oocyte-derived BMP15 but not GDF9 down-regulates connexin43 expression and decreases gap junction intercellular communication activity in immortalized human granulosa cells
Growth through the secondary stage takes several months in humans. It is still largely governed by local paracrine factors rather than circulating hormones, although the follicle gradually becomes responsive to FSH as it approaches the antral transition.
Antral Follicle Formation
The transition from secondary to antral follicle is marked by the appearance of a fluid-filled cavity called the antrum. This is the stage most people picture when they think of an ovarian follicle on an ultrasound, as antral follicles are large enough to be visible with imaging. But how does the fluid get there? Granulosa cells produce large sugar-protein molecules, particularly hyaluronan and versican, which create an osmotic gradient that draws water inward from the blood vessels in the theca layer.9PubMed. Formation of the ovarian follicular antrum and follicular fluid Water channels called aquaporins in the granulosa cells may actively help transport water, though the follicular wall is surprisingly permeable even to large serum proteins.
Antrum formation also requires the granulosa cells to physically rearrange. Cell-cell junctions remodel to let fluid accumulate in pockets, and in some species, the death of centrally located granulosa cells creates space for the cavity to open up. Studies in mice lacking the aquaporin-8 gene found that reduced granulosa cell proliferation and migration actually led to increased antrum formation, because the looser packing of granulosa cells created gaps more readily.10Frontiers in Physiology. Increased Formation of Follicular Antrum in Aquaporin-8-Deficient Mice Is Due to Defective Proliferation and Migration, and Not Steroidogenesis of Granulosa Cells
With the antrum in place, the granulosa layer splits into two functional zones. The mural granulosa cells line the outer wall and are primarily responsible for hormone production. The cumulus cells cluster around the oocyte, maintaining its nutrient supply and signaling environment. This structural division becomes essential in later stages.
Dominant Follicle Selection
Every menstrual cycle, a cohort of antral follicles responds to a rise in FSH from the pituitary gland and begins growing. But in humans (and other species that typically ovulate one egg at a time), only one follicle from that cohort survives to ovulate. The rest die off in a process called atresia. How does the winner get picked?
Rising FSH levels recruit the cohort, but the follicles themselves soon put the brakes on FSH. Their collective estrogen and inhibin production feeds back to the pituitary, driving FSH levels down. As FSH drops, most follicles lose the hormonal support they need and begin degenerating. One follicle, however, manages to keep growing. This dominant follicle appears to have a lower threshold for FSH stimulation, allowing it to survive on falling FSH levels that are too low for its competitors.11PubMed. Mechanisms of follicle selection and development As it matures, the dominant follicle increasingly shifts its dependence from FSH to LH, which sustains its continued growth and differentiation even as FSH drops further.12PubMed. Mechanisms for dominant follicle selection in monovulatory species: a comparison of morphological, endocrine and intraovarian events in cows, mares and women
AMH plays a supporting role in this process as well. Beyond restraining primordial follicle activation, AMH also reduces the sensitivity of growing follicles to FSH, effectively raising the bar that a follicle must clear to continue developing.13Reproduction. Regulation of ovarian function: the role of anti-Mullerian hormone This helps explain why AMH blood levels are used clinically as a marker of ovarian reserve: higher AMH suggests more small growing follicles in the pipeline.
Hormone Production and the Two-Cell Model
By the antral stage, the follicle has become a hormone-producing factory. Estrogen synthesis requires cooperation between the two cell types that surround the follicle. The theca cells, stimulated by LH, produce androgens. The granulosa cells, stimulated by FSH, then convert those androgens into estrogen using an enzyme called aromatase. This division of labor is sometimes called the two-cell, two-gonadotropin model.14PubMed. Follicular oestrogen synthesis: the ‘two-cell, two-gonadotrophin’ model revisited The gene encoding the enzyme needed for androgen synthesis is expressed only in theca cells, while the FSH receptor is found only in granulosa cells, which locks in the partnership.
This arrangement matters clinically. When androgen production becomes excessive relative to the capacity of granulosa cells to convert androgens to estrogen, follicle development can stall. That imbalance is a hallmark of polycystic ovary syndrome.
The Preovulatory Follicle and Ovulation
The dominant follicle reaches the preovulatory (Graafian) stage at roughly 18 to 25 millimeters in diameter in humans. At this point, rising estrogen from the follicle triggers a surge of LH from the pituitary. The LH surge sets off a cascade of events that lead to ovulation within about 24 to 36 hours.
Ovulation itself is sometimes compared to a controlled inflammatory reaction. The LH surge induces enzymes called matrix metalloproteinases and other proteases, such as ADAMTS-1 and cathepsin L, which break down the structural proteins in the follicular wall.15Steroids. Ovulation: a multi-gene, multi-step process At the same time, the cumulus cells around the oocyte undergo expansion, embedding themselves in a matrix of hyaluronic acid that loosens the egg from the follicle wall. The follicular apex thins and eventually ruptures, releasing the oocyte.16PubMed Central. Ovulation: A consequence of acute inflammation cultivated by E2-induced reactive oxygen species and triggered by progesterone withdrawal Progesterone receptor signaling is essential to this process; without it, key proteases are not fully induced and ovulation fails.
Corpus Luteum Formation
After the egg is released, the remains of the follicle do not simply collapse. The granulosa and theca cells undergo a dramatic transformation called luteinization, turning into large, lipid-rich cells that produce progesterone. This new structure is the corpus luteum, and its progesterone output is what prepares the uterine lining for a potential pregnancy. New blood vessels rapidly invade the former follicular cavity in a process driven in part by placental growth factor; when that angiogenesis is disrupted experimentally, luteinization remains incomplete and disorganized.17PubMed Central. Placental Growth Factor Is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles
If pregnancy does not occur, the corpus luteum degenerates after about 10 to 14 days, progesterone falls, and menstruation follows. This degeneration, called luteolysis, involves a complex interplay of signals. If pregnancy does occur, hormonal support from the embryo maintains the corpus luteum for weeks until the placenta takes over progesterone production.
Follicular Atresia and the Fate of Most Follicles
For every follicle that ovulates, hundreds or thousands die. Atresia can strike at virtually any stage, from primordial through antral. A woman is born with somewhere around one to two million primordial follicles, yet only about 400 will ever ovulate over a reproductive lifetime. The rest are eliminated through programmed cell death in the granulosa cells.
Research into the mechanisms of atresia points to a decline in a molecule called NAD+ within granulosa cells. As NAD+ levels fall and the ratio of NAD+ to its reduced form drops, apoptotic pathways activate, triggering the granulosa cells to self-destruct. When the enzymes responsible for recycling NAD+ are impaired, a chain reaction follows: reduced activity of protective enzymes like SIRT1 and SIRT3 leads to excessive activation of the pro-death protein p53.18PubMed. Investigation of NAD+ metabolism alterations during follicular atresia in porcine ovaries and their regulatory mechanisms in granulosa cell apoptosis Atresia is not simply waste; it appears to be a quality-control mechanism ensuring that only the healthiest, best-supported follicles complete the journey.
How the Stages Change With Age
Ovarian aging is essentially the story of the primordial pool shrinking. Both the number and the quality of oocytes decline progressively over the reproductive years.19PubMed Central. Mechanisms of ovarian aging In mouse studies that tracked follicle counts across the lifespan, the number of primordial follicles dropped steeply from youth through middle age, and similar declines were seen in primary, secondary, and antral follicles.20Scientific Reports. Evaluation of inflammation and follicle depletion during ovarian ageing in mice In humans, declining oocyte quantity and quality together drive the age-related fall in fertility, and the menopausal transition happens when the follicle count drops below a critical threshold.21PubMed Central. Ovarian ageing and the impact on female fertility
Inflammation within the ovary also increases with age and may accelerate the loss of remaining follicles. This creates a vicious cycle: fewer follicles mean less AMH production, which in turn may allow the remaining primordial follicles to activate faster than they should, further depleting the reserve.
When Follicle Development Stalls
In polycystic ovary syndrome, follicle development gets stuck at the small antral stage. Women with PCOS often have an unusually high number of antral follicles visible on ultrasound, but none progresses to become a dominant follicle and ovulate. The leading explanation centers on excess androgens within the ovary: androgens promote early follicular growth, producing more small antral follicles than normal. That glut of follicles then disrupts the selection process, partly because the combined AMH output from all those small follicles desensitizes the cohort to FSH, preventing any single follicle from pulling ahead.22Human Reproduction Update. The follicular excess in polycystic ovaries, due to intra‐ovarian hyperandrogenism, may be the main culprit for the follicular arrest
At the cellular level, androgens (particularly dihydrotestosterone) suppress FSH-driven granulosa cell growth by upregulating PTEN expression, the same molecule that keeps primordial follicles dormant. The result is a kind of developmental gridlock: granulosa cells stop dividing, the follicle cannot mature further, and ovulation fails.23Scientific Reports. The effect of androgens on ovarian follicle maturation: Dihydrotestosterone suppress FSH-stimulated granulosa cell proliferation by upregulating PPARγ-dependent PTEN expression Insulin resistance can worsen this by amplifying ovarian androgen production, adding a metabolic layer to what is fundamentally a follicular development problem.24PubMed Central. The role of lncRNA HUPCOS in androgen metabolism and follicle growth arrest in polycystic ovary syndrome
Monitoring Follicles in Clinical Practice
Transvaginal ultrasound is the standard tool for tracking follicular development, especially during fertility treatments. It can visualize antral follicles and measure the diameter of the dominant follicle as it grows toward ovulation. Early comparisons of ultrasound techniques found that real-time sector scanning gave the best results for visualizing ovaries and follicles, with measurements of the dominant follicle correlating strongly across different scanner types.25PubMed Central. Ultrasound monitoring of ovarian follicular development: a comparison real-time and static scanning techniques Modern ultrasound equipment is far more advanced, but the basic principle is the same: you count the antral follicles and watch for one to pull ahead.
Blood tests for AMH complement ultrasound by providing a hormonal readout of the pool of small growing follicles. Together, the antral follicle count on ultrasound and the AMH level give clinicians the most reliable picture of a woman’s ovarian reserve. In assisted reproduction, controlled ovarian stimulation uses exogenous FSH to rescue follicles that would otherwise undergo atresia, coaxing multiple antral follicles to mature simultaneously rather than allowing only one to dominate. The aim is essentially to override the natural selection process for a single cycle, harvesting several mature eggs for fertilization.
Follicular Waves Across Species
Follicle development does not look identical in every mammal, but the basic staged framework is remarkably conserved. Comparative research between mares and women found that the dynamics of the ovulatory follicle wave were strikingly similar: in both species, one lead follicle emerged before its competitors, the relative growth rates during the common growth phase were comparable, and the relative diameter of the dominant follicle from deviation to ovulation scaled proportionally. The main difference was absolute size, with the mare’s dominant follicle about twice as large at each equivalent milestone.26Biology of Reproduction. Comparative Study of the Dynamics of Follicular Waves in Mares and Women
This cross-species similarity is one reason why animal models have been so useful in working out the molecular signals that control each stage. Many of the key pathways described throughout this article were first identified in mouse or rat ovaries and later confirmed in human tissue. That said, not everything translates perfectly. Species that routinely ovulate multiple eggs per cycle, like rodents and pigs, have less stringent dominant-follicle selection, and their AMH dynamics differ accordingly.
Environmental Disruption of Follicle Stages
The intricate signaling that governs each follicular transition makes the process vulnerable to outside interference. Endocrine-disrupting chemicals, a broad category that includes certain pesticides, plasticizers, and industrial compounds, have been linked to altered follicle and corpus luteum numbers, abnormal hormone levels, and impaired ovulatory processes in laboratory studies. Epidemiological data suggest associations with reduced egg yields during IVF and lower pregnancy rates.27PubMed Central. The effects of endocrine-disrupting chemicals on ovarian- and ovulation-related fertility outcomes Chemotherapy is another well-known threat: anticancer drugs can reduce the primordial follicle pool and alter the expression of the very proteins that keep that pool dormant.2PubMed Central. FOXO3 and PTEN expression in the ovary of girls with extra-gonadal cancer with or without chemotherapy treatment prior to cryopreservation This is why fertility preservation through egg or ovarian tissue freezing is offered to young cancer patients before treatment begins.